Close

NovaBay Pharma (NBY) Misses Q1 EPS by 14c

May 11, 2017 4:13 PM EDT

NovaBay Pharma (NYSE: NBY) reported Q1 EPS of ($0.26), $0.14 worse than the analyst estimate of ($0.12). Revenue for the quarter came in at $3.69 million versus the consensus estimate of $3.89 million.

For earnings history and earnings-related data on NovaBay Pharma (NBY) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings, Guidance

Related Entities

Earnings